Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4325034 | 0.78 | DGAT1 (0.39) | DGAT1MAOAMAOB | |
| Hydrazine SCHEMBL10794464 | 0.77 | DGAT1 (0.42) | DGAT1MAOAMAOB | |
| SCHEMBL6951911 | 0.77 | DGAT1 (0.35) | DGAT1MAOAMAOB | |
| SCHEMBL78520 | 0.76 | DGAT1 (0.46) | DGAT1 | |
| SCHEMBL31524998 | 0.76 | DGAT1 (0.37) | DGAT1MAOAMAOB | |
| SCHEMBL27655031 | 0.76 | DGAT1 (0.37) | DGAT1MAOAMAOB | |
| SCHEMBL21008320 | 0.76 | DGAT1 (0.37) | DGAT1 | |
| SCHEMBL21368053 | 0.74 | DGAT1 (0.36) | DGAT1 | |
| SCHEMBL15279401 | 0.74 | DGAT1 (0.36) | DGAT1MAOAMAOB | |
| Guanidine SCHEMBL27275385 | 0.74 | GAA (0.41) | DGAT1MAOAMAOBNOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745910-A | Chemical compound | 安塔比奥公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-110446708-B | Chemical compound | 安塔比奥公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-114615981-A | KRAS G12D inhibitors | 米拉蒂治疗股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-106279369-B | Antifungal agent and application thereof | 奇达拉治疗公司 | 2020-02-11 | — | — | CN | disclosed |
| CN-110003079-A | For making the ligand of imaging cardiac innervation | 兰休斯医疗成像公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-105622463-B | For making the ligand of imaging cardiac innervation | 兰休斯医疗成像公司 | 2019-02-22 | — | — | CN | disclosed |
| CN-104334555-A | Isoxazole beta-lactamase inhibitors | CUBIST PHARM INC | 2015-02-04 | — | — | CN | disclosed |
| EP-2680873-A2 | ANTIFUNGAL AGENTS AND USES THEREOF | Seachaid Pharmaceuticals, Inc. (US) | 2014-01-08 | — | — | EP | disclosed |
| WO-2013029182-A1 | STABLE PEPTIDE-BASED FURIN INHIBITORS | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013029180-A1 | STABLE PEPTIDE-BASED PACE4 INHIBITORS | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2013-03-07 | — | — | WO | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |
| CN-1379666-A | Non-peptide GnRH agents, methods and intermediates for their preparation | AGOURON PHARMA (US) | 2002-11-13 | — | — | CN | disclosed |
| CN-1305492-A | Pyrazinone protease inhibitors | DIMENSIONAL PHARM INC (US) | 2001-07-25 | — | — | CN | disclosed |
| CN-1305454-A | Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-07-25 | — | — | CN | disclosed |
| CN-1303365-A | Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors | DIMENSIONAL PHARM INC (US) | 2001-07-11 | — | — | CN | disclosed |
| EP-1089966-A1 | NOVEL COMPOUNDS USEFUL IN PAIN MANAGEMENT | AstraZeneca AB (SE) | 2001-04-11 | — | — | EP | disclosed |
| EP-1089965-A1 | NOVEL COMPOUNDS | AstraZeneca AB (SE) | 2001-04-11 | — | — | EP | disclosed |
| EP-0730590-B1 | ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS | DU PONT PHARM CO (US) | 2001-01-17 | — | — | EP | disclosed |
| WO-1999067204-A1 | NOVEL COMPOUNDS | ASTRAZENECA AB (SE) | 1999-12-29 | — | — | WO | disclosed |
| WO-1999067205-A1 | NOVEL COMPOUNDS USEFUL IN PAIN MANAGEMENT | ASTRAZENECA AB (SE) | 1999-12-29 | — | — | WO | disclosed |